Loading...
AusCann Group Holdings Ltd
AC8.AX•ASX
HealthcareDrug Manufacturers - Specialty & Generic
$0.04
$0.00(0.00%)
AusCann Group Holdings Ltd (AC8.AX) Stock Overview
Explore AusCann Group Holdings Ltd’s financial performance, market position, analyst ratings, and future outlook.
Stats data is not available for AC8.AXStats details for AC8.AX are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for AC8.AXAnalyst Recommendations details for AC8.AX are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Company Profile
AusCann Group Holdings Ltd does not have significant operations. Previously, it was engaged in the researches, develops, and commercializes various cannabinoid-derived therapeutic products. The company is headquartered in West Perth, Australia.
CEO
Mr. Christopher Mews A.C.I.S., B. Bus, C.P.A.
Employees
27
Headquarters
35 Havelock Street, West Perth, WA
Founded
1988